Quarterly report [Sections 13 or 15(d)]

MARKETABLE SECURITIES

v3.25.1
MARKETABLE SECURITIES
9 Months Ended
Jan. 31, 2025
Marketable Securities  
MARKETABLE SECURITIES

NOTE 4 - MARKETABLE SECURITIES

 

On November 21, 2024, the Company received from the Femasys Notes a payment in Femasys common stock for interest income in the amount of $300,000. The interest income payment was based on the Femasys average stock price on that date of $0.95, therefore, the Company received 315,790 common stock shares. As of January 31, 2025, the current market value of the Femasys common stock shares was $1.18 that generated an unrealized gain of $72,632.

 

Cost and fair value of marketable equity securities at January 31, 2025 are as follows:

                 
    Carrying Value              
    At Fair Market     Value at     Unrealized  
Marketable securities   Value     Cost Basis     Gains  
                   
Equity – stock   $ 372,632     $ 300,000     $ 72,632  

 

The fair value of equity securities has been measured on a recurring basis using Level 1 inputs, which are based on unadjusted quoted market prices within active markets. There have been no changes in valuation approaches or techniques and related inputs.